“GLP-1 Receptor Agonist Drugs As a Protective Factor Against Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus”. Research, Society and Development 10, no. 16 (December 10, 2021): e134101623517. Accessed January 11, 2026. https://rsdjournal.org/rsd/article/view/23517.